Connect with us

Business

Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q4: 2026-02-12 Earnings Summary

EPS of $0.16 misses by $0.00

 | Revenue of $211.90M (16.21% Y/Y) beats by $9.94M

Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call February 13, 2026 2:00 PM EST

Company Participants

Lukas Hartwich – Executive Vice President of Finance
Rick Matros – Chairman, President & CEO
Darrin Smith – Chief Investment Officer, Secretary & Executive VP
Michael Costa – Executive VP, CFO & Treasurer

Advertisement

Conference Call Participants

William John Kilichowski – Wells Fargo Securities, LLC, Research Division
Juan Sanabria – BMO Capital Markets Equity Research
Michael Goldsmith – UBS Investment Bank, Research Division
Austin Wurschmidt – KeyBanc Capital Markets Inc., Research Division
Seth Bergey – Citigroup Inc., Research Division
Michael Stroyeck – Green Street Advisors, LLC, Research Division
Farrell Granath – BofA Securities, Research Division
Alec Feygin – Robert W. Baird & Co. Incorporated, Research Division
Omotayo Okusanya – Deutsche Bank AG, Research Division
Richard Anderson – Cantor Fitzgerald & Co., Research Division

Advertisement

Presentation

Operator

Good day, everyone. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sabra Fourth Quarter 2025 Earnings Call. [Operator Instructions]

I would now like to turn the call over to Lukas Hartwich, Executive Vice President of Finance. Please go ahead, Mr. Hartwich.

Advertisement

Lukas Hartwich
Executive Vice President of Finance

Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2026 and our expectations regarding our tenants and operators, and our expectations regarding our acquisition, disposition and investment plans.

These forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2025, as well as in

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Patrick Industries EVP Amundson sells $568k in stock

Published

on


Patrick Industries EVP Amundson sells $568k in stock

Continue Reading

Business

LARRY KUDLOW: Trumponomics is working, as a midterm victory comes into sight

Published

on

LARRY KUDLOW: The Dow 50,000 Prosperity Rocket Ship

Plenty of good economic news this week, with an outsize gain in jobs, especially private sector jobs. And a much lower-than-expected report on consumer prices.

All this with a stock market hovering near 50,000 amidst booming productivity, low energy prices, and a more than trillion dollar deregulation at EPA. And even a Gallup poll showing a 49-36% rebound in economic confidence.

So you sort of have to wonder why the Wall Street Journal runs an editorial that ‘America is Running out of Patience with Republicans’. 

Advertisement

If there ever was a real affordability issue, right now the Trump Economy is crushing it.

The latest reading from the strong January jobs report showed production workers getting an increase in pay and working more hours. What some economists, including myself, call the wage income proxy, which is hourly earnings times hours worked, jumped in January to 5.6% at an annual rate over the past three months.

Meanwhile, today’s CPI inflation report showed a 2.4% rise over the past three months, so that gives you a 3.2% real wage take-home pay number.  

Let me do it again: 5.6% on wages and hours worked, against only a 2.4% three-month CPI change.

Advertisement

Trumponomics is delivering. 

And the workforce is earning their pay hikes with a tremendous productivity run, and businesses remain very profitable with only a 1.1% increase in unit labor costs.

Technology is booming, demand for power is booming. President Trump is taking the shackles off oil, gas, and coal, so-called baseload energy, by getting rid of the Obama-Biden endangerment finding that was never put into law anyway. So average autos can probably come in somewhere around $2,400 cheaper. Scoring another for the middle class.

Factory construction is booming. It was one of the strongest parts in the January jobs report. And some of that can be directly traced to the President’s tariff-driven reciprocal trade policy.

Advertisement

Plus, 100% immediate depreciation write-offs, creating a huge business capital goods boom, where new investment means stronger employment and wages, and eventually consumer spending power.

While it may be true, as President Trump told me this week, that he and his team have to work harder to get the message out, the fact is the numbers are on his side.

And editorialists who dwell on tired old left-wing Biden-esque criticisms, should really just give it up.

Trumponomics is working, and a midterm election victory for Republicans is very much in sight.

Advertisement
Continue Reading

Business

Apollo Global: Overdone Credit Fears Create A Buying Opportunity (Upgrade)

Published

on

Apollo Global: Overdone Credit Fears Create A Buying Opportunity (Upgrade)

Apollo Global: Overdone Credit Fears Create A Buying Opportunity (Upgrade)

Continue Reading

Business

Sanofi Shares Fall After CEO Change

Published

on

Sanofi Shares Fall After CEO Change

Sanofi SAN -1.87%decrease; red down pointing triangle shares fell after the drugmaker said Belen Garijo, the chief executive of Germany’s Merck MRK 1.91%increase; green up pointing triangle KGaA, would succeed Paul Hudson as CEO after its board decided not to renew his mandate.

The change at the helm of the French company follows a string of clinical setbacks last year that put its shares under pressure and left investors and analysts wondering whether Sanofi would be able to replace sales from blockbuster Dupixent—an anti-inflammatory drug jointly developed with Regeneron—once the medicine goes off patent.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

Telus CEO Darren Entwistle to Step Down, Victor Dodig Named Successor

Published

on

Telus CEO Darren Entwistle to Step Down, Victor Dodig Named Successor

Telus T -3.22%decrease; red down pointing triangle longtime Chief Executive Darren Entwistle will hand over the reins of the Canadian telecom giant, making way for former bank boss Victor Dodig.

Entwistle will retire on June 30 following a 26-year tenure as Telus’s president and CEO, the company said Thursday. Dodig, who has been an independent director on the Telus board for almost four years, becomes CEO designate with immediate effect and will join the company’s leadership team full time May 1 before taking over as CEO at the start of July, Telus said.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

Two men jailed in UK for Islamic State-inspired plot to kill hundreds of Jews

Published

on

Two men jailed in UK for Islamic State-inspired plot to kill hundreds of Jews


Two men jailed in UK for Islamic State-inspired plot to kill hundreds of Jews

Continue Reading

Business

Form 13G LIGHTWAVE ACQUISITION CORP-A For: 13 February

Published

on


Form 13G LIGHTWAVE ACQUISITION CORP-A For: 13 February

Continue Reading

Business

Adobe: Outstanding Business At Outstanding Price (NASDAQ:ADBE)

Published

on

Adobe: Outstanding Business At Outstanding Price (NASDAQ:ADBE)

This article was written by

I am a qualified economist specializing in economic theory and I have been investing and trading since 2005. Since 2018, I have been investing in US equities. Until 2022, I was part of TopStepTrader, having passed the combine for a funded trader. I am a conservative investor, and for a long time, I have been using my model for evaluating companies, based on a mix of quantitative and fundamental analysis. This model allows me to assess objectively almost any public business and answer the question of investment attractiveness. The exceptions are banks, insurance companies and REITs – my analysis does not cover them. I focus on comprehensive and in-depth analysis of financial statements of mega and large caps, trying to update my vision every quarter. My main investing strategy is to regularly buy shares with a portion of my income that I want to hold forever. I want to combine my writing and research skills with my passion for financial statement analysis to give private investors an independent view of large and well-known companies from a facts and figures perspective. My main motivation is to help private investors make informed and well-founded decisions by demonstrating my approach to analysis.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ADBE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I use a strong buy rating, but my approach would be better served by a rating scale from avoid to attractive. Attractive status or strong buy rating relative to ADBE stock is based solely on an analysis of the financial performance of the business without an assessment of the current value, although this analysis will also be carried out towards the end of the article. My opinion may be useful to investors considering whether to include the stock in a long-term portfolio and hold it for a 3-5 year horizon, and it does not constitute a recommendation or trading instruction.

Advertisement

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Continue Reading

Business

Lowe’s cuts 600 corporate and support roles to focus on store employees

Published

on

Lowe’s cuts 600 corporate and support roles to focus on store employees


Lowe’s cuts 600 corporate and support roles to focus on store employees

Continue Reading

Business

Heathrow not crowded but people walk in 'wrong place', says boss

Published

on

Heathrow not crowded but people walk in 'wrong place', says boss

Chief executive Thomas Woldbye says Europeans and Brits keep “crashing into each other” because they walk on different sides.

Continue Reading

Trending

Copyright © 2025